The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Conformational selection or induced fit? 50 years of debate resolved
Open accessAbstract
Exactly 50 years ago, biochemists raised the question of the mechanism of the conformational change that mediates "allosteric" interactions between regulatory sites and biologically active sites in regulatory/receptor proteins. Do the different conformations involved already exist spontaneously in the absence of the regulatory ligands (Monod-Wyman-Changeux), such that the complementary protein conformation would be selected to mediate signal transduction, or do particular ligands induce the receptor to adopt the conformation best suited to them (Koshland-Nemethy-Filmer-induced fit)? This is not just a central question for biophysics, it also has enormous importance for drug design. Recent advances in techniques have allowed detailed experimental and theoretical comparisons with the formal models of both scenarios. Also, it has been shown that mutated receptors can adopt constitutively active confirmations in the absence of ligand. There have also been demonstrations that the atomic resolution structures of the same protein are essentially the same whether ligand is bound or not. These and other advances in past decades have produced a situation where the vast majority of the data using different categories of regulatory proteins (including regulatory enzymes, ligand-gated ion channels, G protein-coupled receptors, and nuclear receptors) support the conformational selection scheme of signal transduction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On the nature of allosteric transitions: A plausible model
Monod, J., Wyman, J., & Changeux, J.-P. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80285-6 · Cited by 8,825
Self-citationSomatic generation of antibody diversity.
Matthyssens, G., Hozumi, N., & Tonegawa, S. (1976) · PubMed · Cited by 3,244
Comparison of Experimental Binding Data and Theoretical Models in Proteins Containing Subunits*
Koshland, D. E., Némethy, G., & Filmer, D. (1966) · Biochemistry · doi:10.1021/bi00865a047 · Cited by 3,013
PERUTZ, M. F. (1970) · Nature · doi:10.1038/228726a0 · Cited by 2,926
Allosteric proteins and cellular control systems
Monod, J., Changeux, J.-P., & Jacob, F. (1963) · Journal of Molecular Biology · doi:10.1016/s0022-2836(63)80091-1 · Cited by 2,233
Self-citationThe role of dynamic conformational ensembles in biomolecular recognition
Boehr, D. D., Nussinov, R., & Wright, P. E. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.232 · Cited by 2,008
Atomic-level characterization of the structural dynamics of proteins
Shaw, D. E., Maragakis, P., Lindorff-Larsen, K., Piana, S., Dror, R. O., Eastwood, M. P., Bank, J. A., Jumper, J. M., Salmon, J. K., Shan, Y., et al. (2010) · Science · doi:10.1126/science.1187409 · Cited by 1,923
Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,257
The Enzymology of Control by Feedback Inhibition
Gerhart, J. C., & Pardee, A. B. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60389-8 · Cited by 1,016
Principles of activation and permeation in an anion-selective Cys-loop receptor
Hibbs, R. E., & Gouaux, E. (2011) · Nature · doi:10.1038/nature10139 · Cited by 995
Crystal structure of the ligand-free G-protein-coupled receptor opsin
Park, J. H., Scheerer, P., Hofmann, K. P., Choe, H.-W., & Ernst, O. P. (2008) · Nature · doi:10.1038/nature07063 · Cited by 903
A Theory of the Structure and Process of Formation of Antibodies*
Pauling, L. (1940) · Journal of the American Chemical Society · doi:10.1021/ja01867a018 · Cited by 838
Adair, G. S., Bock, A. V., & Field, H. (1925) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)85018-9 · Cited by 823
Structure of an Agonist-Bound Human A 2A Adenosine Receptor
Xu, F., Wu, H., Katritch, V., Han, G. W., Jacobson, K. A., Gao, Z.-G., Cherezov, V., & Stevens, R. C. (2011) · Science · doi:10.1126/science.1202793 · Cited by 813
Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA
Chandra, V., Huang, P., Hamuro, Y., Raghuram, S., Wang, Y., Burris, T. P., & Rastinejad, F. (2008) · Nature · doi:10.1038/nature07413 · Cited by 808
Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins
Lefkowitz, R. J., Cotecchia, S., Samama, P., & Costa, T. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90048-o · Cited by 792
Colquhoun, D., & Sakmann, B. (1985) · The Journal of Physiology · doi:10.1113/jphysiol.1985.sp015912 · Cited by 761
Allosteric Mechanisms of Signal Transduction
Changeux, J.-P., & Edelstein, S. J. (2005) · Science · doi:10.1126/science.1108595 · Cited by 747
Self-citationNicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Taly, A., Corringer, P.-J., Guedin, D., Lestage, P., & Changeux, J.-P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2927 · Cited by 703
Self-citationAllostery and cooperativity revisited
Cui, Q., & Karplus, M. (2008) · Protein Science · doi:10.1110/ps.03259908 · Cited by 681
X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation
Bocquet, N., Nury, H., Baaden, M., Le Poupon, C., Changeux, J.-P., Delarue, M., & Corringer, P.-J. (2009) · Nature · doi:10.1038/nature07462 · Cited by 674
Self-citationDNA binding site sequence directs glucocorticoid receptor structure and activity
Meijsing, S. H., Pufall, M. A., So, A. Y., Bates, D. L., Chen, L., & Yamamoto, K. R. (2009) · Science · doi:10.1126/science.1164265 · Cited by 673
Seifert, R., & Wenzel-Seifert, K. (2002) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-002-0588-0 · Cited by 637
How Does a Drug Molecule Find Its Target Binding Site?
Shan, Y., Kim, E. T., Eastwood, M. P., Dror, R. O., Seeliger, M. A., & Shaw, D. E. (2011) · Journal of the American Chemical Society · doi:10.1021/ja202726y · Cited by 614
Langley, J. N. (1905) · The Journal of Physiology · doi:10.1113/jphysiol.1905.sp001128 · Cited by 602
Use of a Snake Venom Toxin to Characterize the Cholinergic Receptor Protein
Changeux, J.-P., Kasai, M., & Lee, C.-Y. (1970) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.67.3.1241 · Cited by 601
Self-citationConformational selection or induced fit: A flux description of reaction mechanism
Hammes, G. G., Chang, Y.-C., & Oas, T. G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907195106 · Cited by 577
Kenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573
THE STEREOCHEMICAL MECHANISM OF THE COOPERATIVE EFFECTS IN HEMOGLOBIN REVISITED
Perutz, M. F., Wilkinson, A. J., Paoli, M., & Dodson, G. G. (1998) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.27.1.1 · Cited by 563
Structural Overview of the Nuclear Receptor Superfamily: Insights into Physiology and Therapeutics
Huang, P., Chandra, V., & Rastinejad, F. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135917 · Cited by 533
Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel
Hilf, R. J. C., & Dutzler, R. (2009) · Nature · doi:10.1038/nature07461 · Cited by 526
The structural basis of agonist-induced activation in constitutively active rhodopsin
Standfuss, J., Edwards, P. C., D’Antona, A., Fransen, M., Xie, G., Oprian, D. D., & Schertler, G. F. X. (2011) · Nature · doi:10.1038/nature09795 · Cited by 476
ON THE COOPERATIVITY OF BIOLOGICAL MEMBRANES
Changeux, J.-P., Thiéry, J., Tung, Y., & Kittel, C. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.57.2.335 · Cited by 434
Self-citationBuilding a new conceptual framework for receptor heteromers
Ferré, S., Baler, R., Bouvier, M., Caron, M. G., Devi, L. A., Durroux, T., Fuxe, K., George, S. R., Javitch, J. A., Lohse, M. J., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio0309-131 · Cited by 394
Structural basis for partial agonist action at ionotropic glutamate receptors
Jin, R., Banke, T. G., Mayer, M. L., Traynelis, S. F., & Gouaux, E. (2003) · Nature Neuroscience · doi:10.1038/nn1091 · Cited by 367
On the nature of allosteric transitions: Implications of non-exclusive ligand binding
Rubin, M. M., & Changeux, J.-P. (1966) · Journal of Molecular Biology · doi:10.1016/0022-2836(66)90097-0 · Cited by 339
Self-citationMutant G-protein-coupled receptors as a cause of human diseases
Schöneberg, T., Schulz, A., Biebermann, H., Hermsdorf, T., Römpler, H., & Sangkuhl, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.008 · Cited by 337
The Oxygen Equilibrium of Hemoglobin and Its Structural Interpretation
Pauling, L. (1935) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.21.4.186 · Cited by 337
Responses of Acetylcholinesterase from Torpedo marmorata to Salts and Curarizing Drugs
CHANGEUX, J.-P. (1966) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14802-5 · Cited by 325
Self-citationCotecchia, S., Exum, S., Caron, M. G., & Lefkowitz, R. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.2896 · Cited by 308
Energy Landscapes as a Tool to Integrate GPCR Structure, Dynamics, and Function
Deupi, X., & Kobilka, B. K. (2010) · Physiology · doi:10.1152/physiol.00002.2010 · Cited by 264
Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes
Smith, N. J., & Milligan, G. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002667 · Cited by 262
Lewis, M. (2005) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2005.04.004 · Cited by 256
Dimers and beyond: The functional puzzles of class C GPCRs
Kniazeff, J., Prézeau, L., Rondard, P., Pin, J.-P., & Goudet, C. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.006 · Cited by 251
Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain.
Bertrand, D., Devillers-Thiéry, A., Revah, F., Galzi, J. L., Hussy, N., Mulle, C., Bertrand, S., Ballivet, M., & Changeux, J. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1261 · Cited by 240
Self-citationConstitutively active mutants of the alpha 2-adrenergic receptor
Ren, Q., Kurose, H., Lefkowitz, R. J., & Cotecchia, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85445-5 · Cited by 238
Enzyme flexibility and enzyme action
Koshland, D. E. (1959) · Journal of Cellular and Comparative Physiology · doi:10.1002/jcp.1030540420 · Cited by 198
Normal Mode Analysis Suggests a Quaternary Twist Model for the Nicotinic Receptor Gating Mechanism
Taly, A., Delarue, M., Grutter, T., Nilges, M., Le Novère, N., Corringer, P.-J., & Changeux, J.-P. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.050229 · Cited by 189
Self-citationExtensions of the Allosteric Model for Haemoglobin
EDELSTEIN, S. J. (1971) · Nature · doi:10.1038/230224a0 · Cited by 185
Self-citationLigand-regulated oligomerization of β2-adrenoceptors in a model lipid bilayer
Fung, J. J., Deupi, X., Pardo, L., Yao, X. J., Velez-Ruiz, G. A., DeVree, B. T., Sunahara, R. K., & Kobilka, B. K. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.267 · Cited by 181
Hibbs, R. E., Sulzenbacher, G., Shi, J., Talley, T. T., Conrod, S., Kem, W. R., Taylor, P., Marchot, P., & Bourne, Y. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.227 · Cited by 164
New looks and outlooks on physical enzymology
Eigen, M. (1968) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500000445 · Cited by 163
Ligand‐directed signalling at β‐adrenoceptors
Evans, B. A., Sato, M., Sarwar, M., Hutchinson, D. S., & Summers, R. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00602.x · Cited by 160
Spontaneous openings of the acetylcholine receptor channel.
Jackson, M. B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3901 · Cited by 159
One-microsecond molecular dynamics simulation of channel gating in a nicotinic receptor homologue
Nury, H., Poitevin, F., Renterghem, C. V., Changeux, J., Corringer, P., Delarue, M. H., & Baaden, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001832107 · Cited by 157
Self-citationChangeux, J., & Rubin, M. M. (1968) · Biochemistry · doi:10.1021/bi00842a601 · Cited by 144
Self-citationActivation of Visual Pigments by Light and Heat
Luo, D.-G., Yue, W. W. S., Ala‐Laurila, P., & Yau, K. (2011) · Science · doi:10.1126/science.1200172 · Cited by 140
A kinetic mechanism for nicotinic acetylcholine receptors based on multiple allosteric transitions.
Edelstein, S. J., Schaad, O., Henry, E., Bertrand, D., & Changeux, J.-P. (1996) · Biological Cybernetics · doi:10.1007/s004220050302 · Cited by 134
Self-citationAspartate Transcarbamylase from Escherichia Coli: Activity and Regulation
Lipscomb, W. N. (1994) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470123140.ch3 · Cited by 134
Palanché, T., Ilien, B., Zoffmann, S., Reck, M.-P., Bucher, B., Edelstein, S. J., & Galzi, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104363200 · Cited by 132
Self-citationAllosteric Receptors: From Electric Organ to Cognition
Changeux, J. (2010) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105741 · Cited by 115
Self-citationNew insights into allosteric mechanisms from trapping unstable protein conformations in silica gels
Viappiani, C., Bettati, S., Bruno, S., Ronda, L., Abbruzzetti, S., Mozzarelli, A., & Eaton, W. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405987101 · Cited by 113
The oligomeric state sets GABAB receptor signalling efficacy
Comps‐Agrar, L., Kniazeff, J., Nørskov-Lauritsen, L., Maurel, D., Gassmann, M., Gregor, N., Prézeau, L., Bettler, B., Durroux, T., Trinquet, E., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.143 · Cited by 107
Anesthetic sites and allosteric mechanisms of action on Cys-loop ligand-gated ion channels
Forman, S. A., & Miller, K. W. (2011) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-010-9419-9 · Cited by 104
Blum, A. P., Lester, H. A., & Dougherty, D. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007140107 · Cited by 101
Taly, A., Corringer, P., Grütter, T., de Carvalho, L. P., Karplus, M., & Changeux, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607477103 · Cited by 99
Self-citationVėlyvis, A., Yang, Y. R., Schachman, H. K., & Kay, L. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703347104 · Cited by 96
Iwata, S., Kamata, K., Yoshida, S., Minowa, T., & Ohta, T. (1994) · Nature Structural Biology · doi:10.1038/nsb0394-176 · Cited by 96
The multiple phenotypes of allosteric receptor mutants.
Galzi, J., Edelstein, S. J., & Changeux, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1853 · Cited by 96
Self-citationDrugs from Emasculated Hormones: The Principle of Syntopic Antagonism
Black, J. W. (1989) · Science · doi:10.1126/science.2569237 · Cited by 95
50th anniversary of the word “allosteric”
Changeux, J. (2011) · Protein Science · doi:10.1002/pro.658 · Cited by 90
Self-citationConformational changes and drug action.
Burgen, A. S. (1981) · PubMed · Cited by 90
G Protein-Coupled Receptor Heteromerization: A Role in Allosteric Modulation of Ligand Binding
Gomes, I., IJzerman, A. P., Ye, K., Maillet, É. L., & Devi, L. A. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070847 · Cited by 88
G Protein Activation by Serotonin Type 4 Receptor Dimers
Pellissier, L. P., Barthet, G., Gaven, F., Cassier, E., Trinquet, E., Pin, J., Marin, P., Dumuis, A., Bockaert, J., Banères, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.201939 · Cited by 83
G protein-coupled receptor structure and function: the impact of disease-causing mutations
Shenker, A. (1995) · Baillière's Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80519-2 · Cited by 81
Sato, M., Horinouchi, T., Hutchinson, D. S., Evans, B. A., & Summers, R. J. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035337 · Cited by 78
Unsuspected pathway of the allosteric transition in hemoglobin
Fischer, S., Olsen, K. W., Nam, K., & Karplus, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011995108 · Cited by 76
Hemoglobin is an honorary enzyme
Brunori, M. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01380-8 · Cited by 64
G‐protein‐coupled receptor oligomers: two or more for what? Lessons from mGlu and GABAB receptors
Pin, J., Comps‐Agrar, L., Maurel, D., Monnier, C., Rives, M., Trinquet, E., Kniazeff, J., Rondard, P., & Prézeau, L. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.179978 · Cited by 62
Stereochemistry of Cooperative Effects in Haemoglobin1
Perutz, M. F. (2015) · KARGER eBooks · doi:10.1159/000394570 · Cited by 59
Transmembrane signaling by GPCRs: Insight from rhodopsin and opsin structures
Choe, H., Park, J. H., Kim, Y. J., & Ernst, O. P. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.018 · Cited by 50
Lewis, M. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.02.023 · Cited by 49
Allosteric Theory: Taking Therapeutic Advantage of the Malleable Nature of GPCRs
Kenakin, T. (2007) · Current Neuropharmacology · doi:10.2174/157015907781695973 · Cited by 46
Fetler, L., Kantrowitz, E. R., & Vachette, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607641104 · Cited by 42
Hemoglobin allostery: Variations on the theme
Bellelli, A., & Brunori, M. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.04.004 · Cited by 40
Conformational Changes in the Nicotinic Acetylcholine Receptor during Gating and Desensitization
Yamodo, I. H., Chiara, D. C., Cohen, J. B., & Miller, K. W. (2009) · Biochemistry · doi:10.1021/bi901550p · Cited by 39
Drugs from emasculated hormones: The principle of syntopic antagonism
Black, J. W. (1989) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02624592 · Cited by 31
Relationships between Structural Dynamics and Functional Kinetics in Oligomeric Membrane Receptors
Edelstein, S. J., & Changeux, J. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.01.050 · Cited by 27
Self-citationFetler, L., & Vachette, P. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4681 · Cited by 27
Doyle, S. A., Beernink, P. T., & Koshland, D. E. (2001) · Biochemistry · doi:10.1021/bi002533q · Cited by 26
West, J. M., Xia, J., Tsuruta, H., Guo, W., O’Day, E. M., & Kantrowitz, E. R. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.022 · Cited by 18
Myasthenic nicotinic receptor mutant interpreted in terms of the allosteric model
Edelstein, S. J., Schaad, O., & Chanceux, J. (1997) · Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie · doi:10.1016/s0764-4469(97)82468-7 · Cited by 17
Self-citationDocking of α-cobratoxin suggests a basal conformation of the nicotinic receptor
Konstantakaki, M., Changeux, J., & Taly, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.126 · Cited by 15
Self-citationConstitutive Activity and Inverse Agonism at the α1a and α1b Adrenergic Receptor Subtypes
Cotecchia, S. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-381296-4.00007-5 · Cited by 6
Structure of Full-Length PPARγ-RXRα: A Snapshot of a Functional Complex?
Moras, D. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.010 · Cited by 5
Cited by
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Insights into Protein–Ligand Interactions: Mechanisms, Models, and Methods
Du, X., Li, Y., Xia, Y.-L., Ai, S.-M., Liang, J., Sang, P., Ji, X.-L., & Liu, S.-Q. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020144 · Cited by 1,657
Role of Molecular Dynamics and Related Methods in Drug Discovery
De Vivo, M., Masetti, M., Bottegoni, G., & Cavalli, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01684 · Cited by 1,297
Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
Liu, Q., Sabnis, Y., Zhao, Z., Zhang, T., Buhrlage, S. J., Jones, L. H., & Gray, N. S. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.12.006 · Cited by 652
Receptor–ligand molecular docking
Guedes, I. A., de Magalhães, C. S., & Dardenne, L. E. (2014) · Biophysical Reviews · doi:10.1007/s12551-013-0130-2 · Cited by 606
Metadata
- Authors
- Changeux, J.-P., & Edelstein, S.
- Venue
- F1000 Biology Reports
- Publisher
- Faculty Opinions Ltd
- Published
- 2011-09-01
- Volume
- 3
- Pages
- 19-19
- ISSN
- 1757-594X (ISSN-L)
- OpenAlex
- W2079370986
- Cited by
- 271
- References
- 95
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.